Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: BIOPHARMA SERVICES USA
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2018-09-13 to 2023-09-13
Current total value of award: $2808265
Description: NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS